Steven Cohen (Trades, Portfolio)'s investment firm, Point72 Asset Management, has recently expanded its investment portfolio by adding shares of Caribou Biosciences Inc (NASDAQ:CRBU). On February 22, 2024, the firm acquired 4,432,602 shares of the biopharmaceutical company, reflecting a significant commitment to the healthcare sector.